BNZSQ - NDC 300-3629-01 LEUPROLIDE ACETATE INJECTION KIT
- MSDS: BNZSQ
- Manufacturer: ABBOTT LABS HOSP PRODUCTS DIV
- Product Name: NDC 300-3629-01 LEUPROLIDE ACETATE INJECTION KIT
- National Stock Number: 6505-01-310-7326
Product Identification
Product ID:NDC 300-3629-01 LEUPROLIDE ACETATE INJECTION KIT
MSDS Date:10/01/1990
FSC:6505
NIIN:01-310-7326
MSDS Number: BNZSQ
Responsible Party
NORTH CHICAGO, IL 60064-3502
US
Emergency Phone: (312) 937-7901
Info Phone: (312) 937-7901
Cage: 60060
Contractor
Telephone: 847-935-7177
Cage: 60060
Ingredients
LEUPROLIDE ACETATE
CAS: 74381-53-6
RTECS: OH6390000
Hazards
Routes of Entry: Inhalation:YES Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INJECTION: INCREASE IN LH, FSH, &
MALE/FEMALE SEX HORMONES, REDUCTIONS IN HORMONES TO CASTRATE OR
MENOPAUSAL LEVEL, HOT FLASHES, SWEATS, IMPOTENCE, DECREASED
LIBIDO/TESTICULAR SIZE, HEADACHE, MOOD CHA NGES, AMENORRHEA,
VAGINAL DRYNESS, FERTILITY SUPPRESSION, DECREASED BONE DENSITY.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:INJECTION: INCREASE IN LH, FSH, & MALE/FEMALE
SEX HORMONES, REDUCTIONS IN HORMONES TO CASTRATE OR MENOPAUSAL
LEVEL, HOT FLASHES, SWEATS, IMPOTENCE, DECREASED LIBIDO/TESTICULAR
SIZE, HEADACHE, MOOD CHA NGES, AMENORRHEA, VAGINAL DRYNESS,
FERTILITY SUPPRESSION, DECREASED BONE DENSITY.
Medical Cond Aggravated by Exposure:DUE TO TEMPORARY INCREASE OF SEX
HORMONE LEVELS DURING FIRST FEW WEEKS OF TREATMENT, ISOLATED CASES
OF WORSENING IN SIGNS/SYMPTOMS OF HORMONALLY-DEPENDENT CONDITIONS
HAVE BEEN REPORTED.
First Aid
First Aid:EYES/SKIN: FLUSH W/COPIOUS AMOUNTS OF WATER.
INHALATION/INGESTION: REMOVE TO FRESH AIR. THERE IS NO KNOWN
ANTIDOTE. PROVIDE SYMPTOMATIC OR SUPPORTIVE CARE, MONITORING
HORMONE/SEXUAL FUNCTION AS NECESS ARY. OBTAIN MEDICAL ATTENTION IN
ALL CASES.
Fire Fighting
Extinguishing Media:USE APPROPRIATE MEDIA FOR UNDERLYING CAUSE OF FIRE.
Fire Fighting Procedures:WEAR PROTECTIVE CLOTHING & SELF-CONTAINED
BREATHING APPARATUS.
Accidental Release
Spill Release Procedures:WEAR PROTECTIVE EQUIPMENT. SWEEP UP SPILLAGE.
AVOID DUST. PLACE IN APPROPRIATE CONTAINER FOR DISPOSAL. VENTILATE
& WASH SPILL AREA.
Handling
Handling and Storage Precautions:STORE ONLY IN CONTAINERS APPROVED FOR
STORAGE OF THIS MATERIAL. AVOID DUST.
Other Precautions:AVOID CONTACT W/SOLID OR ITS SOLUTIONS. WOMEN OF
CHILD BEARING POTENTIAL MUST BE EXCLUDED FROM WORKING DIRECTLY
W/PRODUCT WHICH IS NOT PACKAGED IN CLOSED CONTAINER.
Exposure Controls
Respiratory Protection:WEAR APPROVED RESPIRATOR W/HIGH EFFICIENCY
PARTICULATE FILTER OR SUPPLIED-AIR (IF HANDLING POWDER).
Ventilation:LOCAL VENTILATION TO CONTROL DUST AT ITS SOURCE
Protective Gloves:RUBBER, CHEMICALLY COMPATIBLE
Eye Protection:SAFETY GLASSES & GOGGLES
Supplemental Safety and Health
LH: LUTEINIZING HARMONE; FSH: FOLLICLE-STIMULATING HARMONE. CONTINUOUS
ADMINISTRATION OF THERAPEUTIC DOSES ACTS AS POTENT, BUT REVERSIBLE
INHIBITOR OF GONADOTROPIN SECRETION BY THE PITUITARY, RESULTIN G IN
INHIBITION OF OVARIAN & TESTICULARSTEROID PRODUCTION.
Chemical Properties
Solubility in Water:COMPLETE
Appearance and Odor:WHITE, FLOCCULENT POWDER.
Stability
Stability Indicator/Materials to Avoid:YES
HYPOCHLORITE SOLUTIONS
Disposal
Waste Disposal Methods:DISPOSE OF MATERIAL IN ACCORDANCE W/APPLICABLE
FEDERAL, STATE, & LOCAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.